GAVRETO

This brand name is authorized in Austria, Ecuador, Estonia, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, Romania, United States

Active ingredients

The drug GAVRETO contains one active pharmaceutical ingredient (API):

1 Pralsetinib
UNII 1WPE73O1WV - PRALSETINIB

Pralsetinib is a potent protein kinase inhibitor that selectively targets oncogenic RET fusions (KIF5BRET and CCDC6-RET). In non-small cell lung cancer (NSCLC), RET fusions are one of the main oncogenic drivers.

Read about Pralsetinib

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
GAVRETO Capsule FDA, National Drug Code (US) MPI, US: SPL/PLR
GAVRETO Hard capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01EX23 L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors
Discover more medicines within L01EX23

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 6644-MEE-1021
Country: EE Ravimiamet Identifier(s): 1867765, 1867776, 1867787
Country: FR Base de données publique des médicaments Identifier(s): 67194402
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 9015, 9016, 9017
Country: IT Agenzia del Farmaco Identifier(s): 049771013, 049771025, 049771037
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1093820, 1093821, 1093822
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100460685
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68296001, W68296002
Country: US FDA, National Drug Code Identifier(s): 72064-210

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.